Shafeeq Ladha
- Neurology top 2%
- Amyotrophic Lateral Sclerosis Research 9
- Peripheral Neuropathies and Disorders 6
- Autoimmune Neurological Disorders and Treatments 3
- Myasthenia Gravis and Thymoma 3
- Genetics top 5%
- Neurogenetic and Muscular Disorders Research 5
- Neurology top 10%
- Amyotrophic Lateral Sclerosis Research 9
- Peripheral Neuropathies and Disorders 6
- Autoimmune Neurological Disorders and Treatments 3
- Myasthenia Gravis and Thymoma 3
-
- Lysosomal Storage Disorders Research 6
-
- Genetic Neurodegenerative Diseases 3
-
- Glycogen Storage Diseases and Myoclonus 2
- Co-authors
- Qiang LiuFu‐Dong ShiP. James B. DyckJonathan D. GlassSamuel ShiEric A. MacklinMerit CudkowiczRobert J. Spinner
- Partner nations
- United StatesBelgiumFrance
In The Last Decade
Shafeeq Ladha
27 papers receiving 649 citations
Peers
Comparison fields: 5 of 68
- Neurology 487
- Genetics 221
- Neurology 75
- Biological Psychiatry 8
- Biochemistry 22
Countries citing papers authored by Shafeeq Ladha
This map shows the geographic impact of Shafeeq Ladha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shafeeq Ladha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shafeeq Ladha more than expected).
Fields of papers citing papers by Shafeeq Ladha
This network shows the impact of papers produced by Shafeeq Ladha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shafeeq Ladha. The network helps show where Shafeeq Ladha may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shafeeq Ladha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 9 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 5 | |
| 4 | 2022 | 31 | |
| 5 | 2021 | 1 | |
| 6 | 2021 | 2 | |
| 7 | 2021 | 1 | |
| 8 | 2020 | 68 | |
| 9 | NEO1 AND NEO-EXT STUDIES: PHARMACODYNAMIC/EXPLORATORY BIOMARKER AND SAFETY ASSESSMENTS FOLLOWING REPEAT AVALGLUCOSIDASE ALFA DOSING FOR UP TO 4.5 YEARS IN PATIENTS WITH LATE-ONSET POMPE DISEASE | 2019 | 1 |
| 10 | 2017 | 33 | |
| 11 | 2016 | 1 | |
| 12 | 2014 | 198 | |
| 13 | 2013 | 5 | |
| 14 | 2013 | 69 | |
| 15 | 2012 | 7 | |
| 16 | 2008 | 25 | |
| 17 | 2008 | 5 | |
| 18 | 2006 | 19 | |
| 19 | 2006 | 44 | |
| 20 | 2005 | 10 |
About Shafeeq Ladha
Shafeeq Ladha is a scholar working on Neurology, Genetics and Neurology, having authored 31 papers that have together received 667 indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (9 papers), Peripheral Neuropathies and Disorders (6 papers), Lysosomal Storage Disorders Research (6 papers), Neurogenetic and Muscular Disorders Research (5 papers), Autoimmune Neurological Disorders and Treatments (3 papers), Myasthenia Gravis and Thymoma (3 papers), Genetic Neurodegenerative Diseases (3 papers) and Glycogen Storage Diseases and Myoclonus (2 papers). The work is most often cited by research in Neurology (487 citations), Genetics (221 citations) and Neurology (75 citations). Shafeeq Ladha has collaborated with scholars based in United States, Belgium and France. Frequent co-authors include Qiang Liu, Fu‐Dong Shi, P. James B. Dyck, Jonathan D. Glass, Samuel Shi, Eric A. Macklin, Merit Cudkowicz, Robert J. Spinner, Kimberly K. Amrami and Rup Tandan. Their work appears in journals such as The Lancet, Nature Communications and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.